← Back to Search

Behavioral Intervention

sipIT for Kidney Stones

N/A

Recruiting

Research Sponsored by Penn State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 or older

Previous diagnosis of symptomatic kidney stone in the past 5 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from the end of the intervention period (3 months) to the maintenance change at 6 months

Awards & highlights

Study Summary

This trial aims to understand how people change their behavior and stick to it during and after participating in a 3-month sipIT intervention.

Who is the study for?

This trial is for individuals who are currently experiencing kidney stones. The specific eligibility criteria to participate in the study have not been provided, so it's important to contact the research team for detailed information on who can join.Check my eligibility

What is being tested?

The sipIT intervention is being tested in this study. It aims to understand how behavior changes, continues over time, and adherence are influenced during and after a three-month period of using sipIT.See study design

What are the potential side effects?

Potential side effects of the sipIT intervention are not specified here. Participants interested should inquire with the research team about any risks or adverse reactions associated with this intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have had a painful kidney stone in the last 5 years.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from the end of the intervention period (3 months) to the maintenance change at 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from the end of the intervention period (3 months) to the maintenance change at 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and from the end of the intervention period (3 months) to the maintenance change at 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Urine volume (intervention)

Secondary outcome measures

Urine volume (maintenance)

Trial Design

1Treatment groups

Experimental Treatment

Group I: sipITExperimental Treatment1 Intervention

Participants will receive an educational handout about physical activity, a connected water bottle with its companion mobile application. For months 1-3, participants will receive lapse-contingent reminders to drink delivered by text message.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Penn State UniversityLead Sponsor

355 Previous Clinical Trials

125,602 Total Patients Enrolled

1 Trials studying Kidney Stones

3,299 Patients Enrolled for Kidney Stones

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How large is the patient cohort enrolled in this medical study?

"Indeed, as per the details on clinicaltrials.gov, this investigation is actively seeking participants. Initially shared on January 10th, 2024, and last refreshed on February 13th of the same year, it aims to recruit 155 patients from a single site."

Answered by AI

Are participants currently being sought for enrollment in this study?

"Affirmative. Records from clinicaltrials.gov confirm that this research study is presently in search of suitable candidates. The trial was initially published on January 10, 2024, with the most recent update occurring on February 13, 2024. A total of 155 participants are sought at a single investigational site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Dual-process Mechanisms of Action for sipIT Intervention Effects in Patients With Urolithiasis

David E Conroy 2024. "Dual-process Mechanisms of Action for sipIT Intervention Effects in Patients With Urolithiasis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06269783.

All > Kidney Stone